"Vasopressins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
| Descriptor ID |
D014667
|
| MeSH Number(s) |
D06.472.699.631.692.781 D12.644.400.900 D12.644.456.925 D12.644.548.691.692.781 D12.776.631.650.937
|
| Concept/Terms |
Vasopressins- Vasopressins
- beta-Hypophamine
- beta Hypophamine
- Antidiuretic Hormones
|
Below are MeSH descriptors whose meaning is more general than "Vasopressins".
Below are MeSH descriptors whose meaning is more specific than "Vasopressins".
This graph shows the total number of publications written about "Vasopressins" by people in this website by year, and whether "Vasopressins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasopressins" by people in Profiles.
-
Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. J Am Coll Cardiol. 2013 Feb 05; 61(5):571-9.
-
Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012 Nov; 5(6):750-8.
-
Potential for overuse of corticosteroids and vasopressin in septic shock. Crit Care. 2012 Sep 06; 16(5):447.
-
New approaches to out-of-hospital cardiac arrest. Mt Sinai J Med. 2006 Jan; 73(1):440-8.
-
Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology. 2001 Mar; 120(4):946-54.